|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 维那卡兰>> 市场分析报告 |
维那卡兰市场分析报告 |
|
Cardiome Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... cardiovascular function. Products in Development Vernakalant for Atrial Fibrillation Vernakalant is a new chemical entity ... -term prevention of atrial fibrillation recurrence. Vernakalant Vernakalant (oral) is being evaluated as an oral maintenance ... Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Drugs in Development by ... The State of Merck & Co ... included in this report Gardasil Betrixaban Vernakalant Ridaforolimus Remicade Narlaprevir Grass (Phleum ... |